伊伐布雷定治疗婴儿伴副通路相关难治性室上性心动过速1例。

IF 0.9 4区医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiology in the Young Pub Date : 2025-06-03 DOI:10.1017/S1047951125001945

Ayse Sulu, Pelin Kosger, Eylem Kiral, Birsen Ucar

{"title":"伊伐布雷定治疗婴儿伴副通路相关难治性室上性心动过速1例。","authors":"Ayse Sulu, Pelin Kosger, Eylem Kiral, Birsen Ucar","doi":"10.1017/S1047951125001945","DOIUrl":null,"url":null,"abstract":"Ivabradine has been shown to be safe and effective in treating congenital and postoperative junctional ectopic tachycardia in children; however, in recent years, case reports have suggested that it may also be used to treat automaticity-related ectopic atrial tachycardia and focal atrial tachycardia. Here, we discussed a case in which we used ivabradine to induce sinus rhythm in a 38-day-old baby who had resistant supraventricular tachycardia and investigated potential accessory pathway-related tachycardia.","PeriodicalId":9435,"journal":{"name":"Cardiology in the Young","volume":" ","pages":"1-4"},"PeriodicalIF":0.9000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ivabradine treatment for an infant with potential accessory pathway-related refractory supraventricular tachycardia.\",\"authors\":\"Ayse Sulu, Pelin Kosger, Eylem Kiral, Birsen Ucar\",\"doi\":\"10.1017/S1047951125001945\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Ivabradine has been shown to be safe and effective in treating congenital and postoperative junctional ectopic tachycardia in children; however, in recent years, case reports have suggested that it may also be used to treat automaticity-related ectopic atrial tachycardia and focal atrial tachycardia. Here, we discussed a case in which we used ivabradine to induce sinus rhythm in a 38-day-old baby who had resistant supraventricular tachycardia and investigated potential accessory pathway-related tachycardia.\",\"PeriodicalId\":9435,\"journal\":{\"name\":\"Cardiology in the Young\",\"volume\":\" \",\"pages\":\"1-4\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2025-06-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiology in the Young\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1017/S1047951125001945\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology in the Young","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/S1047951125001945","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

摘要

伊伐布雷定治疗儿童先天性和术后结性异位心动过速安全有效；然而，近年来的病例报告表明，它也可用于治疗自动性相关异位性房性心动过速和局灶性房性心动过速。在这里，我们讨论了一个病例，我们使用伊伐布雷定诱导一个38天大的婴儿窦性心律谁抵抗室上性心动过速和调查潜在的副通路相关的心动过速。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Ivabradine treatment for an infant with potential accessory pathway-related refractory supraventricular tachycardia.

Ivabradine has been shown to be safe and effective in treating congenital and postoperative junctional ectopic tachycardia in children; however, in recent years, case reports have suggested that it may also be used to treat automaticity-related ectopic atrial tachycardia and focal atrial tachycardia. Here, we discussed a case in which we used ivabradine to induce sinus rhythm in a 38-day-old baby who had resistant supraventricular tachycardia and investigated potential accessory pathway-related tachycardia.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cardiology in the Young 医学-小儿科

CiteScore

1.70

自引率

10.00%

发文量

715

审稿时长

4-8 weeks

期刊介绍： Cardiology in the Young is devoted to cardiovascular issues affecting the young, and the older patient suffering the sequels of congenital heart disease, or other cardiac diseases acquired in childhood. The journal serves the interests of all professionals concerned with these topics. By design, the journal is international and multidisciplinary in its approach, and members of the editorial board take an active role in the its mission, helping to make it the essential journal in paediatric cardiology. All aspects of paediatric cardiology are covered within the journal. The content includes original articles, brief reports, editorials, reviews, and papers devoted to continuing professional development.